Current Edition

1. Pic - for - Bio Catallunia

The BioRegion of Catalonia: What’s Behind the European Country with More Pharma Companies per Capita?

Last autumn, Barcelona hosted the CPhI Worldwide for the first time, and it was a record-breaking year for the event. In their article, Nuria Pelaez, …

Continue Reading →
1. New - Pic for the - Rise of cell

The Rise of Cellular Immunotherapy and Global IP Strategies

We are at the beginning of a new age in cancer therapy. With a large and growing number of patents and applications in this space, …

Continue Reading →
preparing for IDMP

Preparing for IDMP: The Latest Advice on How to Ensure a Smooth Transition

The forthcoming ISO IDMP standards governing pharmaceutical product information recording have far-reaching implications for the way companies capture, collate, organise and report a very wide …

Continue Reading →
1. Pic for Expanding Markets

Expanding Markets: Where Next? A Regional Regulatory Roundup

Globalisation and the growing efforts to standardise submission requirements and formats internationally continue to open up new markets for life sciences companies. Yet, there are …

Continue Reading →
Pic - for Diversity

Got Diversity? Of Course You Do. Now, What Are You Going to Do With It?

In her piece, Rosalie Harrison, an International Management Consultant with Borderless, addresses the benefits of inclusion & diversity. She tells us that inclusion is the …

Continue Reading →
1. New - Pic for Transdermal

Quality by Design in the Development: Benefit or Bureaucratic Burden?

Petra Botzem and Dr Thomas Hille of LTS Lohmann answer this provoking question in their paper on the ICH guideline Q8, with focus on Transdermal …

Continue Reading →
accurate protein electrostatics

Accurate Protein Electrostatics Add a New Dimension to Structure-based Drug Design

The combination of advanced molecular force fields and improved visualisation capabilities has enabled chemists to expand their ligand-only view of the electrostatics of their system …

Continue Reading →
early interventions to reduce

Early Interventions to Reduce the Impact of Immunogenicity on the Development of Biopharmaceuticals

The development of biological therapeutics has led to remarkable clinical benefits in many indications. But, despite this success, the induction of anti-drug antibodies (ADAs) due …

Continue Reading →
1. Pic - for Needle Free

Needle-free Injection – Eradicating Diseases to Improve Global Health

Needle-free injection technology has evolved significantly over the last 50 years and is now accepted in many routine immunisation settings as a safe and effective …

Continue Reading →
automated accountability

Automated Accountability: Maintaining a Chain of Custody from Release to Destruction

New solutions are proliferating to improve the efficiency of the clinical research function within pharmaceutical companies and CROs. In her article, Theodora Sarver of Almac …

Continue Reading →